![Franco Lori](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Franco Lori
Algemeen Directeur bij Virostatics Srl
Profiel
Franco Lori is the founder of Virostatics Srl, which he founded in 2005 and where he currently holds the title of President & Chief Executive Officer.
In 2012-2013, he worked as a Director at Power of The Dream Ventures, Inc. Dr. Lori holds a doctorate degree from the University of Pavia and the University of Parma.
Actieve functies van Franco Lori
Bedrijven | Functie | Begin |
---|---|---|
Virostatics Srl
![]() Virostatics Srl Pharmaceuticals: MajorHealth Technology Virostatics Srl is a privately held small pharmaceutical company based in Sassari, Italy. The Italian company is dedicated to discovering and developing novel compounds for the treatment of cancers and viral diseases. The company focuses on novel, selective, host cell kinase targeted inhibitors and inherently hindering the oncogene myc. The team and advisors combine scientific, business, legal, and technology expertise, spanning from translational science through preclinical and clinical drug development. Virostatics has developed a bioaerosol system to test nebulized drug treatments, inhalers, disinfectants, or devices for virucidal activity in a state-of-the-art biosafety level 3 facility. The company has developed a robust pipeline of proprietary compounds to distinguish themselves from the competition through their unique kinase selectivity, efficacy, and safety profiles. The company was founded by Franco Lori, who has been the CEO since incorporation. | Algemeen Directeur | 01-01-2005 |
Eerdere bekende functies van Franco Lori
Bedrijven | Functie | Einde |
---|---|---|
Power of The Dream Ventures, Inc.
![]() Power of The Dream Ventures, Inc. BiotechnologyHealth Technology Power of the Dream Ventures, Inc. engages in the acquisition and development of technology. It operates through the Biotecchnology and Software divisions. The firm specializes in environmental technologies, power generation and storage, software products and services, biotechnology, medical devices, and disruptive technologies. The company was founded by Viktor Rozsnyay on August 17, 2006 and is headquartered in Budapest, Hungary. | Directeur/Bestuurslid | 31-05-2013 |
Opleiding van Franco Lori
University of Pavia | Doctorate Degree |
University of Parma | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Power of The Dream Ventures, Inc.
![]() Power of The Dream Ventures, Inc. BiotechnologyHealth Technology Power of the Dream Ventures, Inc. engages in the acquisition and development of technology. It operates through the Biotecchnology and Software divisions. The firm specializes in environmental technologies, power generation and storage, software products and services, biotechnology, medical devices, and disruptive technologies. The company was founded by Viktor Rozsnyay on August 17, 2006 and is headquartered in Budapest, Hungary. | Health Technology |
Virostatics Srl
![]() Virostatics Srl Pharmaceuticals: MajorHealth Technology Virostatics Srl is a privately held small pharmaceutical company based in Sassari, Italy. The Italian company is dedicated to discovering and developing novel compounds for the treatment of cancers and viral diseases. The company focuses on novel, selective, host cell kinase targeted inhibitors and inherently hindering the oncogene myc. The team and advisors combine scientific, business, legal, and technology expertise, spanning from translational science through preclinical and clinical drug development. Virostatics has developed a bioaerosol system to test nebulized drug treatments, inhalers, disinfectants, or devices for virucidal activity in a state-of-the-art biosafety level 3 facility. The company has developed a robust pipeline of proprietary compounds to distinguish themselves from the competition through their unique kinase selectivity, efficacy, and safety profiles. The company was founded by Franco Lori, who has been the CEO since incorporation. | Health Technology |